Steris PLC (STE) Stake Increased by Addenda Capital Inc.
Addenda Capital Inc. lifted its stake in shares of Steris PLC (NYSE:STE) by 20.7% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 9,513 shares of the medical equipment provider’s stock after buying an additional 1,631 shares during the quarter. Addenda Capital Inc.’s holdings in Steris were worth $750,000 as of its most recent SEC filing.
Several other hedge funds also recently added to or reduced their stakes in STE. Janus Henderson Group PLC grew its position in shares of Steris by 1,972.4% during the second quarter. Janus Henderson Group PLC now owns 7,679,507 shares of the medical equipment provider’s stock worth $625,880,000 after buying an additional 7,308,950 shares in the last quarter. BlackRock Inc. grew its position in shares of Steris by 33.4% during the second quarter. BlackRock Inc. now owns 7,032,984 shares of the medical equipment provider’s stock worth $573,188,000 after buying an additional 1,760,879 shares in the last quarter. Koch Industries Inc. acquired a new stake in shares of Steris during the second quarter worth approximately $1,089,000. FMR LLC grew its position in shares of Steris by 33.1% during the second quarter. FMR LLC now owns 3,454,533 shares of the medical equipment provider’s stock worth $281,544,000 after buying an additional 859,228 shares in the last quarter. Finally, State Street Corp grew its position in shares of Steris by 53.2% during the second quarter. State Street Corp now owns 2,336,074 shares of the medical equipment provider’s stock worth $190,392,000 after buying an additional 811,622 shares in the last quarter. 89.40% of the stock is owned by institutional investors and hedge funds.
Steris PLC (STE) opened at $91.67 on Friday. Steris PLC has a one year low of $65.26 and a one year high of $93.39. The stock has a market capitalization of $7,691.29, a price-to-earnings ratio of 23.31 and a beta of 1.27. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.18 and a current ratio of 2.80.
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 20th. Investors of record on Wednesday, November 22nd were paid a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a yield of 1.35%. The ex-dividend date of this dividend was Tuesday, November 21st. Steris’s dividend payout ratio (DPR) is presently 73.81%.
A number of analysts have recently weighed in on the stock. Zacks Investment Research raised shares of Steris from a “hold” rating to a “buy” rating and set a $101.00 price target for the company in a research report on Monday, October 9th. Raymond James Financial reissued a “market perform” rating and set a $100.00 price target on shares of Steris in a research report on Wednesday, January 3rd. KeyCorp reissued a “buy” rating and set a $91.00 price target on shares of Steris in a research report on Tuesday, October 17th. Finally, TD Securities raised their price target on shares of Steris from C$14.00 to C$16.00 and gave the stock a “buy” rating in a research report on Thursday, November 9th. Three analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Steris currently has a consensus rating of “Buy” and a consensus price target of $79.50.
In other Steris news, VP John Adam Zangerle sold 3,650 shares of the firm’s stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $88.00, for a total value of $321,200.00. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Michael J. Tokich sold 11,000 shares of the firm’s stock in a transaction on Monday, October 23rd. The shares were sold at an average price of $92.00, for a total value of $1,012,000.00. Following the completion of the sale, the insider now owns 58,588 shares in the company, valued at $5,390,096. The disclosure for this sale can be found here. Company insiders own 2.55% of the company’s stock.
WARNING: “Steris PLC (STE) Stake Increased by Addenda Capital Inc.” was published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States and international copyright laws. The original version of this piece can be accessed at https://theolympiareport.com/2018/01/13/steris-plc-ste-stake-increased-by-addenda-capital-inc.html.
Steris Company Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.